Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.

Description

Revolutionizing the way heart failure is identified, the EchoGo Heart Failure platform leverages artificial intelligence to enhance precision in detecting HFpEF from echocardiograms. Developed in partnership with the Mayo Clinic, this innovative solution simplifies the detection process, achieving remarkable accuracy from just a single apical 4-chamber view, addressing the challenges that have long hindered identification of this condition. As the first AI-driven platform dedicated to HFpEF detection in echocardiography, Ultromics sets the standard in this field, making it a leader in the use of AI for cardiac imaging. Our advanced technology not only allows for earlier and more efficient identification of heart failure but also aims to improve the overall quality of life for patients. Through our user-friendly and secure cloud-based Software-as-a-Service (SaaS) platform, Ultromics seamlessly integrates with existing echocardiography systems, providing labs with the tools necessary for precise heart failure detection and effective risk stratification. This capability has the potential to significantly lower hospitalization rates related to heart failure, ultimately benefiting healthcare systems and patients alike. As we continue to innovate, our commitment remains to transform cardiac care for the better.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Artrya

Country

Australia

Website

www.artrya.com

Vendor Details

Company Name

Ultromics

Country

United Kingdom

Website

www.ultromics.com

Product Features

Product Features

Medical Imaging

Automated Routing
Comparison View
Compliance Management
Data Import / Export
Diagnostic Reporting
Image Analytics
Treatment Planning
Workflow Management

Alternatives

Alternatives

Merlin CardioMotion Reviews

Merlin CardioMotion

Central Data Networks
HeartLab Pulse Reviews

HeartLab Pulse

HeartLab